Association between obesity measured by different parameters and severity of psoriasis

International Journal of Dermatology

Volumn 52, Issue 2, 2013, Pages 177-181

  Duarte, Gleison Vieira ^a   Oliveira, Maria de Fatima S P ^a   Cardoso, Thiago M ^a   Follador, Ivonise ^a   Silva, Thadeu S ^a   Cavalheiro, Carolina M A ^a   Nonato, Walker ^a   Carvalho, Edgar M ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b National Institute of Science and Technology for Tropical Diseases   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PSORIASIS; RATING SCALE; SCORING SYSTEM; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BODY MASS INDEX; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PREVALENCE; PSORIASIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84873057794     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05270.x     Document Type: Article

References (23)

1. Kormeili T, Lowe NJ, Yamauchi PS. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; US experiences. Br J Dermatol 2004; 151: 3-15.
2. Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26: 314-320.
3. Sommer DM, Jenisch S, Suchan M, et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-328.
4. Kremers HM, McEvoy MT, Dann FJ, et al. Heart disease in psoriasis. J Am Acad Dermatol 2007; 57: 347-354.
5. Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835.
6. Lindegård B. Diseases associated with psoriasis in a general population of 159, 200 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.
7. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
8. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-1534.
9. Wellen KE, Hotasmiligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-1788.
10. Hamminga EA, van der Lely AJ, Neumann HA, et al. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006; 67: 768-773.
11. Jullien D. Physiopathologie du syndrome métabolique. Ann Dermatol Venereol 2008; 135(Suppl.): 243-248.
12. Boehncke WH, Boehncke S, Schön MP. Managing co-morbid disease in patients with psoriasis. BMJ 2010; 15: 340:b5666.
13. Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008; 20: 416-422.
14. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva: WHO, 2000.
15. Instituto Brasileiro de Geografia e Estatística. Diretoria de Pesquisas. Coordenação de Índices de Preços, Pesquisa de Orçamentos Familiares 2002-2003. Rio de Janeiro, RJ: IGBE, 2003.
16. Lwanga SK, Lemeshow S. Sample Size Determination in Health Studies: A Practical Manual. Geneva: World Health Organization 1991.
17. Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust 2003; 179: 580-585.
18. Tanaka S, Togashi K, Rankinen T, et al. Sex differences in the relationships of abdominal fat to cardiovascular disease risk among normal-weight white subjects. Int J Obes Relat Metab Disord 2004; 28: 320-323.
19. Lloyd-Jones DM, Hong Y, Labarthe D, et al. American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond. Circulation 2010; 121: 586-613.
20. Huang YH, Yang LC, Hui RY, et al. Relationships between obesity and the clinical severity of psoriasis in Taiwan. J Eur Acad Dermatol Venereol 2010; 24: 1035-1039.
21. Bongiorno M, Doukaki S, Rizzo D, et al. The prevalence of obesity in patients with moderate to severe psoriasis in Sicily populations. J Eur Acad Dermatol Venereol 2010; 24: 92-93.
22. Shapiro J, Cohen AD, David M, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56: 629-634.
23. Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 2008; 159: 342-350.